Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
7 Unfortunately, insulin remains a cornerstone therapy for patients with uncontrolled or prolonged disease
We invite you to take the next steps towards a healthier, more confident version of yourself
For patients with type 2 diabetes, NICE guidance recommends that GLP-1 treatment should be continued only if there is adequate improvement in HbA1c and weight after 6 months
MEDVi does not require long-term contracts, and patients can cancel at any time
L., Traystman, M
Retatrutide is an investigational triple agonist that simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
US$ 29.16
US$ 22.55
US$ 22.52
US$ 26.76
